Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona by Weber, C. et al.
Functionalization of Liposomes with Hydrophilic Polymers Results
in Macrophage Uptake Independent of the Protein Corona
Claudia Weber,† Matthias Voigt,‡ Johanna Simon,†,§ Ann-Kathrin Danner,∥ Holger Frey,∥
Volker Mailan̈der,†,§ Mark Helm,‡ Svenja Morsbach,*,† and Katharina Landfester†
†Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
‡Institute of Pharmacy and Biochemistry, Johannes Gutenberg-University, Staudingerweg 5, 55128 Mainz, Germany
§Department of Dermatology, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55131
Mainz, Germany
∥Institute of Organic Chemistry, Johannes Gutenberg-University, Duesbergweg 10-14, 55128 Mainz, Germany
*S Supporting Information
ABSTRACT: Liposomes are established drug carriers that are employed to transport and deliver hydrophilic drugs in the body.
To minimize unspeciﬁc cellular uptake, nanocarriers are commonly modiﬁed with poly(ethylene glycol) (PEG), which is known
to minimize unspeciﬁc protein adsorption. However, to date, it has not been studied whether this is an intrinsic and speciﬁc
property of PEG or if it can be transferred to hyperbranched polyglycerol (hbPG) as well. Additionally, it remains unclear if the
reduction of unspeciﬁc cell uptake is independent of the “basic” carrier at which a surface functionalization with polymers is
usually applied. Therefore, we studied the protein corona of diﬀerently functionalized liposomes (unfunctionalized vs PEG or
hbPG-functionalized) using PEGylated and PGylated lipids. Their cellular uptake in macrophages was compared. For all three
liposomal samples, rather similar protein corona compositions were found, and alsomore importantlythe total amount of
proteins adsorbed was very low compared to other nanoparticles. Interestingly, the cellular uptake was then signiﬁcantly
changed by the surface functionalization itself, despite the adsorption of a small amount of proteins: although the PEGylation of
liposomes resulted in the abovementioned decreased cell uptake, functionalization with hbPG lead to enhanced macrophage
interactionboth in the media with and without proteins. In comparison to other nanocarrier systems, this seems to be a
liposome-speciﬁc eﬀect related to the low amount of adsorbed proteins.
■ INTRODUCTION
Drug delivery plays an increasingly important role in modern
nanomedicine, where nanocarriers are designed to transport a
drug to a speciﬁc target location in the body. The advantages
of such a delivery system include in particular the protection of
the active component from degradation by the metabolism, as
well as the decrease of systemic side eﬀects.1−3
Among the diﬀerent delivery systems, liposomes are a
valuable class of nanocarriers for several reasons. They are
spherical vesicles composed of one or multiple phospholipid
bilayers. Because of the amphiphilic character of the
phospholipids, the membrane bilayer displays an aqueous
core and a hydrophilic outer surface as well as a lipophilic
membrane interspace. Therefore, depending on their polarity,
a high variety of lipophilic and hydrophilic drugs can be
encapsulated, either in the membrane or in the core,
respectively. Additionally, by choice of natural or synthetic
(phospho)lipids as components, liposomes may be designed to
be biocompatible and even biodegradable. These factors
render liposomes promising drug carriers.4−6 Moreover, they
already found their way into the market, for example, as the
formulation Doxil, which contains the chemotherapeutic drug
doxorubicin encapsulated in a poly(ethylene glycol) (PEG)-
ylated liposome,7,8 as well as in a non-PEGylated liposome
formulation called Myocet9 and others.10
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To predict the behavior of potential nanocarriers in a
biological system, it is necessary to consider and analyze the
protein adsorption on the surface of the nanomaterial.11,12
Liposomes are no exception here, as they also adsorb proteins
on their surface, as shown by Caracciolo.13 This adsorption
process occurs as soon as the nanomaterial comes into contact
with body ﬂuids, for example, via intravenous injection into the
bloodstream. The drug carrier is confronted with a high
amount of proteins and other biomolecules, which adsorb onto
the material’s surface to form the so-called protein
corona.14−18 Thereby, the adsorbed proteins cover the
liposomal surface, thus contributing to its biological identity.
For many other colloidal nanomaterials, it has been shown that
this biological identity determines the organism’s response
toward the nanocarrier, inﬂuencing cell uptake, clearance, and
body distribution.19
Depending on the binding aﬃnity, the protein corona can be
divided into the so-called hard and soft corona, according to
the respective experimental accessibility. The hard corona
consists of proteins that exhibit a high binding aﬃnity and that
are directly adsorbed onto the nanomaterial’s surface. These
proteins are tightly bound and show long residence times,
which allows to easily isolate and analyze them, for example, by
centrifugation.11,12 Soft corona proteins on the other hand are
more loosely bound and show high exchange rates in a
biological medium. Because of the low binding aﬃnities and
highly dynamic behavior, the isolation of proteins from the soft
corona is experimentally challenging.12,14,20 To access the
loosely bound proteins, we already successfully implemented
asymmetric ﬂow ﬁeld-ﬂow fractionation (AF4) in our previous
work.21 AF4 is a chromatography-like separation technique,
whose separation principle is based on diﬀusion coeﬃcients
and thereby separates the sample according to size. Because of
the lack of a stationary phase, only minimum shear stress is
applied to the sample. Consequently, it is a very mild
technique, which can also separate free proteins from fragile
analytes like protein−particle complexes including strongly and
weakly bound proteins or other self-assembled systems like
liposomes or micelles, which in some cases (depending on
their molecular composition) are too fragile to be centri-
fuged.22,23
Even liposomes formed from natural phospholipids are still
recognized as foreign objects by the body and are therefore
rapidly cleared from the body by the mononuclear phagocytic
system.4 To prevent this rapid clearance, hydrophilic long-
chain polymers can be attached to the liposomal surface, with
the most prominent being PEG.6 The attachment of these
polymers potentially decreases the unspeciﬁc protein adsorp-
tion and forms “stealth” liposomes, which show a longer blood
circulation time and decreased clearance by the immune
system.24−28
Caracciolo et al. investigated the protein corona of
PEGylated liposomes and lipoplexes as well as the ability of
diﬀerent PEG chain lengths to decrease unspeciﬁc cell
uptake.13,29−31 However, the biological behavior of liposomes
functionalized with polymers exhibiting a diﬀerent structure
such as hyperbranched polyglycerol (hbPG) has not been
analyzed with regard to the protein corona to this point. This
polymer with its tree-like structure provides a hydroxyl group
on each branch end, leading to a high hydrophilicity
comparable to PEG, but with more possible functionalization
sites for targeted delivery (Figure 1).32−34
So far, PEG- and hbPG-functionalized liposomal systems
were already analyzed with respect to cellular uptake,35 and a
comparison by Wagener et al. with respect to their in vivo fate
by positron emission tomography imaging found a comparable
biodistribution in mice but diﬀerences in splenic uptake
depending on the functionalization.36 However, the protein
corona, as well as possible functionalization eﬀects on a cellular
level, have not been studied to date.
In this paper, we analyzed the inﬂuence of the above-
mentioned liposome surface functionalizations (unfunctional-
ized, PEG, and hbPG) on the protein corona. We evaluated the
separation by AF4 compared to the usually applied
centrifugation to isolate the protein corona.12,21 By combining
these two techniques, the inﬂuence of the surface functional-
ization of liposomes on the soft and the hard protein corona
was investigated. Moreover, we evaluated the inﬂuence of the
diﬀerent surface functionalities in the presence and absence of
proteins on the biological response by executing cell uptake
experiments in macrophages.
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We show that despite the striking similarities in the protein
corona, the uptake behavior varies signiﬁcantly between the
linear and hyperbranched stealth-type structures, which
correlates with a generally low adsorbed protein mass. We
conclude that the intrinsic properties of the “stealth”
functionalization itself can have a strong and sometimes
superseding impact on cellular uptake and accordingly on the
biological identity of liposomal formulations, depending on the
overall amount of adsorbed proteins.
■ EXPERIMENTAL SECTION
Materials. Phosphate-buﬀered saline (PBS) and Sephacryl S500-
HR were procured from Sigma-Aldrich (USA), whereas ethanol
(99.5%) and cholesterol (Chol) were acquired from Carl Roth,
Germany. A Milli Q device (Merck Millipore, Germany) was used to
obtain demineralized water. Egg phosphatidyl choline (EPC) and
mPEG-DSPE (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[methoxy(polyethylene glycol)-3000], both from Lipoid, Germany)
were used for liposome formulation. The dialkyl-based hbPG
amphiphiles were synthesized as described in the Supporting
Information,33 where also the polymer characterization can be
found. The membrane dye DiI (1,1′-dioctadecyl-3,3,3′,3′-tetramethy-
lindocarbocyanine perchlorate) was purchased from Thermo Fisher
Scientiﬁc.
Human Blood Plasma. In total, 10 healthy participants donated
their blood plasma at the Transfusion Center of the University Clinic
of Mainz, Germany, according to standard guidelines, which was then
combined in a pooled batch. The blood plasma was stored at −20 °C
and centrifuged before use (20 000 g and 4 °C for 1 h, Sigma 3-30K,
Germany) to eliminate protein precipitates and cell fragments.
Liposome Formulation by Dual Centrifugation. All lipids and
amphiphilic polymers were dissolved in ethanol and stored at −20 °C.
After thawing at room temperature, the stock solutions of Chol (20
mg mL−1), EPC (50 mg mL−1), and amphiphilic polymer (20 mg
mL−1) were combined in a polymerase chain reaction (PCR) tube
(Kisker Biotech, Steinfurt, Germany) to yield the intended
compositions. The unfunctionalized bare liposomes (L-un) consisted
of 55:45 mol % of EPC−Chol. For liposomes functionalized with
PEG or hbPG, 5 mol % of EPC was substituted with either mPEG-
DSPE (2750 g mol−1) or amphiphilic dialkyl-based hbPG polymer
(2750 g mol−1), resulting in a composition of 55:40:5 mol % of EPC−
Chol−PEG/hbPG. A 0.2 mol % of the membrane dye DiI was added
to each composition. The combined lipid solutions with a total lipid
mass of 5 mg were dried in a SpeedVac vacuum centrifuge
(Eppendorf, Hamburg, Germany) at 30 °C for at least 6 h and
then in a lyophilization unit (Alpha 2-4 LD Christ, Osterode am Harz,
Germany) for at least 24 h. PBS (9.3 μL) was added to the dry lipids
and incubated for 10 min at room temperature. After adding 71 mg of
ceramic beads (SiLiBeads ZY, 0.3−0.4 mm, Sigmund Lindner,
Warmensteinach, Germany), the PCR tube was subjected to a dual
centrifuge (Rotanta 400 with a prototype dc-rotor, Hettich,
Tuttlingen, Germany) in 3D-printed insets for PCR tubes (in-house
Helm Group, Johannes Gutenberg University, Mainz, Germany) for
20 min at 2500 rpm. The obtained vesicular phospholipid gel was
then diluted with 28.5 μL of PBS and subjected again to dual
centrifugation for 2 × 2 min at 2500 rpm while turning the reaction
tube by 180° in between. The highly concentrated resulting liposome
suspension was stored at 4 °C until usage.
Liposome Puriﬁcation. Preparative size exclusion chromatog-
raphy was performed via an Agilent 1100 System (Agilent, Germany)
to remove the nonencapsulated cargo and free lipids from the
nanocarrier solution. A volume of 60 μL of the liposome suspension
as obtained after dual centrifugation was injected into the system
running with PBS at a ﬂow rate of 1 mL min−1. A BioRad UNO Q1
column (BioRad, Munich, Germany) ﬁlled with Sephacryl S500-HR
was used for separation. A multiwavelength detector (G1365A Agilent
1100 Series, Germany) was used for the detection of the absorption of
DiI-labeled liposomes at 550 nm. An automated fraction collector
collected the resulting puriﬁed liposome solution with a volume of
600 μL.
Light Scattering. The presented light scattering (LS) experiments
were performed with an ALV spectrometer (ALV-GmbH, Germany).
The setup consists of a goniometer and an ALV/LSE-5004 multiple-
tau full-digital correlator with 320 channels. As a light source, a He−
Ne laser was used at a wavelength of 632.8 nm. The samples were
ﬁltered through Millex LCR 0.45 μm syringe ﬁlters (Merck,
Germany) into cylindrical quartz cuvettes (18 mm diameter, Hellma,
Germany). To remove the dust from the cuvettes, they were cleaned
in an acetone fountain prior to usage. Liposome samples were
prepared in a concentration of 0.001 mg mL−1 in PBS. The shown
experiments were performed in triplet, and the CONTIN
algorithm37,38 was used for data analysis.
Zeta Potential. A Malvern Zetasizer Nano series (UK) with
disposable folded capillary cells was used to determine the zeta-
potential (ζ-potential) of the liposome samples. The liposome
solutions were diluted to a concentration of 0.1 mg mL−1 in 1 mM
KCl.
Protein Corona Preparation. The liposomes were diluted in
PBS containing 5% human blood plasma to give a ﬁnal concentration
of 2 mg mL−1. Under constant agitation, the dispersion was incubated
for 1 h at 37 °C.
The obtained liposome−protein complexes (see below) were
resuspended in the corresponding solvent. To quantify the protein
concentration, the Pierce 660 nm Protein Assay (Thermo Scientiﬁc,
Germany) was used according to the manufacturer’s instruction.
Separation of Liposomes with Protein Corona by Cen-
trifugation. Centrifugation at 20 000 g at 4 °C for 1 h (Sigma 3-30K,
Germany) removed unbound proteins. The resulting pellet consisted
of liposomes with adsorbed proteins and was resuspended in 1 mL of
PBS and subsequently washed by three centrifugation steps at 20 000
g and 4 °C for 1 h. After the last centrifugation step, the sample was
resuspended in 200 μL of PBS. The samples were dried by a
SpeedVac Concentrator (Savant DNA120, Thermo Scientiﬁc, USA)
and resuspended again to align the sample preparation to the AF4
procedure.
Separation of Liposomes with Protein Corona by Asym-
metric Flow Field-Flow Fractionation. The used Postnova
AF2000 system was equipped with an autosampler, the tip and
focus pumps, a degasser, a smart stream splitter, and a fraction
collector. A stainless steel frit covered with a regenerated cellulose
membrane with a molecular cutoﬀ of 10 kDa and a 500 μm spacer
formed the separation channel. As detectors, a ﬂuorescence detector
(1260 Inﬁnity, Agilent Technologies, USA) at 549/565 nm and a UV
detector (SPD-20A, Postnova, Germany) at 280 nm were used. Data
evaluation was executed with an AF2000Control 2.0.8.0 (Postnova,
Germany).
The mixture of liposomes and proteins was separated under the
following ﬂow conditions: the channel ﬂow was split to result in a
detector ﬂow of 0.2 mL min−1. The initial crossﬂow was 1 mL min−1
and kept constant for 7.2 min. Then it was decreased exponentially
over 20 min to a crossﬂow of 0.05 mL min−1, which was kept constant
for another 7 min. A second exponential decrease was used over 20
min to lower the crossﬂow to 0 mL min−1. The separation was
continued without the crossﬂow for another 30 min. PBS was used as
a carrier liquid.
The samples were prepared as described above, and a sample
volume of 50 μL was injected. After the the fractions were collected
by the fraction collector, they were dried in a SpeedVac and then
resuspended in 350 μL of H2O for further analysis.
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electropho-
resis. A protein mass of 1 μg in a volume of 16.25 μL was combined
with 2.5 μL of the NuPAGE sample reducing agent and 6.25 μL of the
NuPAGE lithium dodecyl sulfate sample buﬀer. After an incubation
step at 70 °C for 10 min, the mixture was applied on a NuPAGE 10%
Bis−Tris Protein Gel. SeeBlue Plus2 Pre-Stained Standard (all
Invitrogen, Thermo Fisher Scientiﬁc, USA) served as a molecular
ladder. Electrophoresis was carried out at 100 V for 1.5 h in the
NuPAGE MES SDS running buﬀer.
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The SilverQuest Silver Staining Kit (Thermo Fisher Scientiﬁc,
USA) was used according to manufacturer’s instructions to stain the
gel.
Transmission Electron Microscopy. A volume of 2 μL of the
corresponding liposome sample, embedded in 1% trehalose with 4%
uranyl acetate, was placed on a lacey grid, and measurements were
executed on a FEI Tecnai F20 transmission electron microscope with
a working voltage of 200 kV. An Ultrascan 1000 (Gatan, USA)
charge-coupled device camera was used to obtain the electron
micrographs, and the images were collected with the Digital
Micrograph software (Gatan, USA).
Detection of Corona Proteins (IgG) on the Surface of
Liposomes by Flow Cytometry. Liposomes (1 μg) were incubated
for 30 min at room temperature with 5 μL of a protein-labeling
reagent. Zenon Alexa Fluor 647 human immunoglobulin G (IgG)
labeling reagent (200 μg mL−1 as provided by Thermo Fisher, USA)
served for this purpose. The solution was ﬁlled up to 1 mL with PBS.
An Attune NxT ﬂow cytometer (Thermo Fisher, USA) was used for
measurement. A dot plot (SSC vs YL1in logarithmical scale)
displayed the liposomes, whereas the negative control was deﬁned
as liposomes without corona and set to 1% of Alexa Fluor 647-positive
liposomes.
Cellular Uptake. RAW264.7 cells (obtained from ATCC TIB-71)
were cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM,
Gibco, USA). The medium was supplemented with 2 mM glutamine,
100 mg mL−1 of streptomycin, 100 U mL−1 of penicillin, and 10%
fetal bovine serum (all Invitrogen, Germany).
At 80% conﬂuency, the cells were split, and after detaching, the
cells were seeded out in a cell culture medium in 24-well plates (100
000 cells/well). The medium was changed to a serum-free medium
after 24 h. Liposomes were added to the cell culture medium to
achieve a ﬁnal concentration of 7.5 or 75 μg mL−1, and the mixture
was incubated with cells for 2 or 24 h at 37 °C. For ﬂow cytometry
analysis on an Attune NxT ﬂow cytometer (Thermo Fisher, USA),
the cells were detached with 2.5% trypsin (Gibco, Germany).
Confocal Laser Scanning Microscopy. For confocal laser
scanning microscopy (CLSM) experiments, 50 × 104 cells
(RAW264.7) were seeded in Ibidi iTreat μ-dishes (IBIDI, Germany)
for 24 h, washed with PBS, and kept in DMEM without additional
proteins for 2 h. In the following step, liposomes with and without
corona were added to cells for either 2 or 24 h at concentrations of 7.5
or 75 μg mL−1. Subsequently, the cells were washed with PBS and
then ﬁxed for 15 min with Roti-Histoﬁx 4% (Carl Roth GmbH,
Germany). Staining of the cell membrane was achieved by CellMask
Deep Red (dilution of 1:5000 in PBS, Thermo Fisher, USA). Images
were taken on a Leica TCS SP5 II microscope with an HC PL APO
CS 63×/1.4 oil objective using the LAS AF 3000 software, and
detection took place in a serial scan mode. Liposomes are
pseudocolored in green and the cell membrane is pseudocolored in
red.
Statistical Analysis. For the comparison of two experimental
groups, an unpaired Student’s t test assuming equal variances was
performed. The calculated p-values were deﬁned as follows: *p < 0.05,
**p < 0.01, ***p < 0.001. Not signiﬁcant diﬀerences are marked as
n.s.
■ RESULTS AND DISCUSSION
Liposomes were formulated by dual centrifugation, a rather
new and easy-to-use “in-vial” homogenization technique for
fast and reproducible liposome formulation within the single-
digit milligram range of the total lipids (for the principle, see
Figure 2A).39,40 This method allows aseptic formulation of up
to 90 individual liposome samples within 30 min, even for
experimental materials with limited availability. For the
following experiments, three diﬀerent liposome formulations
were chosen. Besides investigating a conventional, unfunction-
alized liposome sample (L-un) with the same lipid
composition as that of Myocet, two liposome samples with
potential stealth functionalizations were also analyzed: lip-
osomes exhibiting PEG chains (L-PEG) as in Doxil linked to
the headgroup of DSPE (Figure 2B) as well as liposomes with
hbPG (L-hbPG) on the surface attached to the hydroxyl group
of a 1,2-bis-n-hexadecyl glyceryl ether. For these systems, we
consider the initial liposome components forming the lipid
double layer (such as EPC, Chol, and DSPE) as the “base
material”, whereas PEG and hbPG represent additional surface
functionalizations. In case of a liposomal system, the base
material is very similar to cell membranes, so that the base
carrier could be considered as a “body-own” material. The
Figure 2. (A) Principle of dual centrifugation. The sample is subjected to the sample holder 1, which rotates contrary to the main axis 2. (B)
Schematic structure of each liposomal composition together with the chemical structures of the used components, EPC, Chol, hbPG, and mPEG-
DSPE.
Table 1. Composition and Physicochemical Characteristics of All Used Liposomes
sample compositiona Rh/nm Rg/nm ρ ratio
b Rg/Rh PD.I.
c ζ-potential/mV
L-un 55 mol % EPC, 45 mol % Chol 86 ± 9 81 ± 8 0.94 0.08 ± 0.03 −20 ± 1
L-PEG 50 mol % EPC, 45 mol % Chol, 5 mol % mPEG-DSPE 61 ± 6 68 ± 7 1.15 0.10 ± 0.03 −26 ± 1
L-hbPG 50 mol % EPC, 45 mol % Chol, 5 mol % hbPG 91 ± 9 94 ± 9 1.03 0.13 ± 0.06 −21 ± 1
aAbbreviations see Figure 2. bρ ratio equals 1 for hollow spheres. cPD.I. The cumulant analysis of the autocorrelation function at a scattering angle
of 90° reveals the given PD.I.s.
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liposome structure, individual components, composition, and
physicochemical characteristics of all liposome samples are
shown in Figure 2B and Table 1.
At low grafting densities, in the so-called “mushroom
regime”, PEG chains can freely move without direct
interaction. With increasing grafting density and size of the
polymer, the PEG chains begin to sterically impede each other
and therefore extend like brushes, increasing the liposome
membrane thickness. According to Lee and Larson,41 the
surface of liposomes functionalized with 5 mol % of PEG3000
should be completely covered with the polymers in the brush
regime. We tentatively suggest that the rather compact
architecture of the hbPG structure may lead to dense surface
coverage of the liposomes already at lower concentration of
polymer lipids than the linear PEG chains that can be present
in a rather extended conformation. Accordingly, we assume for
both L-PEG and L-hbPG that the highest possible function-
alization density was reached.
The liposomes were incubated with 5 vol % citrate plasma to
form the protein corona. The 5 vol % plasma was chosen to
not overload the AF4 channel with proteins but still provide an
excess of free proteins. The newly formed liposome−protein
corona complexes were then separated from the medium by
AF4 or by centrifugation, respectively. The former preparation
was used for the analysis of the whole complex including most
of the soft protein corona, whereas the latter represented the
standard analysis of the hard protein corona. AF4 was used
because of its particular suitability for fragile and self-
assembled systems (e.g., liposomes or micelles), which often
cannot be separated from free proteins by other means. In our
case, the liposome samples were suﬃciently stable to be
centrifuged because of their high Chol content. Hence, we
were able to compare the protein corona after AF4 with the
one obtained after centrifugation.
The AF4 elugrams of all liposomes are displayed in Figure 3.
The green line represents the elution of the pristine liposomes.
Noticeably, all liposomes show a diﬀerent elution proﬁle
depending on their surface functionalization. In theory,
interactions between the sample and the AF4 membrane
would be expected to be minimal or nonexistent. However, in
practice, for some surface functionalizations, the liposomes
seem to interact preferably with the regenerated cellulose
membrane. L-un and L-PEG demonstrate deﬁned elution
peaks, even though the L-PEG peak shows slightly more peak
tailing, whereas L-hbPG interacts strongly with the membrane,
which retards the elution and results in a constant elution of
the sample over the remaining separation time. The high
number of hydroxyl end groups at hbPG most probably causes
the strong interaction with the membrane. Interestingly, also
after plasma incubation (red line), the strong interactions with
the membrane still occur. This indicates that the proteins do
not cover the surface functionalization completely and a
signiﬁcant amount of the hydroxyl end groups are still
accessible for membrane interactions.
Figure 3. AF4 elugrams of all liposomes incubated with 5% plasma are shown in red. The individual elugrams are given as a reference, pure plasma
in blue and pristine liposomes in green. The lower graph always represents the UV detector signal at 280 nm, whereas the upper one shows the
ﬂuorescence intensity. The fractions that were collected for further analysis are indicated by the gray box.
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The shoulder in all elugrams at 62 min corresponds to the
time at which the crossﬂow is stopped. Subsequently, no
retention force acts on the sample anymore, and the remaining
species that are left in the channel at that moment elute at
once. Thus, no further analysis was performed on this last
fraction. Free proteins are expected to elute ﬁrst from the
separation channel, as, according to the AF4 principle, the
smallest components in a sample have the shortest retention
time. In agreement with this, the plasma protein elution takes
place in the ﬁrst 25 min as seen in the reference elugram of
pure plasma (blue line, Figure 3). The red line represents the
incubated mixture of pristine liposomes and blood plasma. The
signal of the mixed sample nicely correlates with the pure
components. The successful separation of incubated liposomes
from free plasma proteins was conﬁrmed by the distinct elution
time. Indeed, free plasma proteins present in the mixture were
eluting until 25 min, whereas the liposome signal just starts at
that time. The origin of the signal cannot be identiﬁed by the
UV detector alone; hence, a ﬂuorescence signal was recorded
to verify that the second peak was generated by the
ﬂuorescently labeled liposomes and not by protein artifacts
or something else. Thereby, the second peak between 25 and
50 min was identiﬁed as that of the corresponding liposomes
presumably with proteins bound. The AF4 results indicate that
an interaction between the proteins and the liposomes must
have taken place, as the peak shape of the liposomes slightly
changed in all cases after incubation with the plasma. For
further analysis of the liposome−protein complexes, fractions
were collected as indicated by the gray boxes in each elugram.
To compare the protein corona after AF4, the sample was
also separated via centrifugation. Therefore, the sample was
centrifuged at 4 °C for 1 h at 20 000g to pellet the liposome−
protein complex and remove the free proteins in the
supernatant. Subsequently, the sample was washed for another
three times with PBS and resuspended. In the last step, the
proteins were detached and afterward quantiﬁed via a Pierce
protein assay. For all three samples, the protein-containing
solution was then concentrated to the highest possible extent
(see Experimental Section). Still, the amount of protein
detected in the assay was low compared to other more
hydrophobic non-PEGylated nanoparticle systems, where
amounts in the range of 3−4 mg m−2 are typical.12,42 More
speciﬁcally, the obtained values were above the limit of
detection (LOD = 0.075), but below the limit of quantiﬁcation
(LOQ = 0.095) (for these samples corresponding to 0.3 and
0.7 mg m−2, respectively), for all three liposomal formulations
(for the details of calculation, see Supporting Information).
Accordingly, the detected protein amounts for all formulations
cannot be reliably compared to each other, but they certainly
were below 0.7 mg m−2, which is in the range of other
hydrophilic nanocarriers.12 The protein compositions of the
coronas obtained after AF4 and centrifugation were
determined by liquid chromatography−mass spectrometry
(LC−MS) in addition to a plasma reference, as shown in
Figure 4. The identiﬁed proteins were grouped according to
their function to represent the most abundant protein types.
Proteins that showed the most signiﬁcant diﬀerences are
displayed individually. A detailed list with all identiﬁed proteins
can be found in the Supporting Information.
Interestingly, when comparing the protein corona patterns
between the diﬀerently functionalized liposomes, the identiﬁed
proteins varied only to some extent. Compared to pure plasma,
the relative amount of albumin was lower in all cases but still
enough to constitute the main protein in the corona. This
decrease of albumin was the most dominant for L-hbPG after
centrifugation and for L-un after AF4. Also, the amount of
apolipoprotein AI (Apo AI) slightly increased for all samples
and especially for L-hbPG after AF4. Depending on the
preparation of the corona, however, more signiﬁcant diﬀer-
ences were obtained concerning the protein fractions. Most
prominent are the changes regarding coagulation and tissue
leakage proteins, which were signiﬁcantly increased after
centrifugation compared to AF4. Two proteins which stand
out are the histidine-rich glycoprotein and coagulation factor
XII which were signiﬁcantly enriched after centrifugation for L-
hbPG. On the other hand, immunoglobulins, albumin, and
acute phase proteins were more abundant after AF4. In
general, immunoglobulins and albumin are mostly known as
proteins with lower binding aﬃnities and, therefore, part of the
soft protein corona, which is supported by our data. Previously,
for diﬀerent kinds of PEGylated nanomaterials, an enrichment
of apolipoproteins was reported,42,43 which surprisingly was
not the case for the PEGylated liposome sample. Also, the
functionalization with hbPG did not result in a strong
attraction of apolipoproteins besides Apo AI, although the
monomer building blocks are in principle similar to PEG. It
seems that for this liposomal system the diﬀerent surface
functionalizationswith the exception of slight changes
possibly induced by hbPGdid not signiﬁcantly change the
properties of the surface with regard to the protein interaction,
as already observed for other nanocarriers. Instead, the
hydrophilic base material underneath the hydrophilic polymers
(PEG and hbPG) forming the liposomal membranes
Figure 4.MS data of the protein corona. Panel (A) shows the coronas
of the diﬀerent liposomes after AF4, compared to plasma and (B)
shows the same for the coronas after centrifugation. Signiﬁcant
proteins are displayed individually. Experiments were performed with
two biological replicates containing three technical replicates each.
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(phospholipids and Chol) apparently was mainly responsible
for determining the protein pattern.
To make sure that the corona obtained after AF4 can indeed
be compared with the one obtained after centrifugation, it is
important to exclude the possibility that the observed corona
proteins are just co-eluting with the liposomes. In this respect,
an assay was conducted, in which a ﬂuorescently labeled Fab
fragment (antigen-binding fragment) selective for the Fc
region (fragment-crystallizable region) of all IgG types was
incubated with the liposome−protein mixtures after AF4 and
after centrifugation, to form complexes with a speciﬁc protein
of the protein corona. Only if the selected proteins are actually
attached on the liposomal surface, the formed complex of
liposome, protein, and labeling agent is large enough to be
detected by ﬂow cytometry (Figure 5A). For this test, IgG was
chosen as the protein to be tested, as it was found as a highly
abundant component in all coronas. The results are displayed
in Figure 5B. The ﬂuorescence signal of the ﬂuorescently
labeled anti-IgG antibody fragment is directly proportional to
the number of liposomes with IgG in the corona. From the
results, it can be conﬁrmed that the investigated proteins were
constituents of the corona after centrifugation and AF4 and
also that the amount of the immunoglobulins after AF4 was
signiﬁcantly higher. This is in good agreement with the results
of the LC−MS experiment (Figure 4). Therefore, we conclude
that IgG was indeed part of the liposomal protein corona for all
samples and that the obtained protein pattern is not a result of
a co-elution eﬀect.
Additionally, the corona formation around the liposomes
was visualized44 with transmission electron microscopy (TEM,
see Figure 5C). The spherical liposome structure was
preserved during the centrifugation process, which is not
Figure 5. (A) Schematic illustration of the experimental design. (B) Liposomes were incubated with human plasma for 1 h. Protein-coated
liposomes were either centrifuged to remove unbound proteins or applied to AF4. Secondary ﬂuorescently labeled antihuman IgG antibodies were
incubated with liposomes for 30 min in the dark. The ﬂuorescence intensity of secondary ﬂuorescently labeled antibodies, which were bound to
liposomes, was detected by ﬂow cytometry. *p < 0.05, **p < 0.01, ***p < 0.001. (C) TEM micrograph with two magniﬁcations of liposomes
incubated with plasma after centrifugation. The arrows indicate protein corona formation.
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universally valid for all liposomes. The liposomes were
comparably stable because of the high amount of Chol that
was incorporated into the lipid membrane. When zoomed in
on the sample, even parts of the protein corona itself could be
observed as indicated by the red arrows.
As the protein coronas were quite similar for all liposome
samples, with only L-hbPG showing slight deviations with
regard to their corona composition, the inﬂuence of the
diﬀerent surface functionalizations on the cellular uptake by
macrophages (RAW264.7) was investigated. A decreased
uptake of a nanocarrier by macrophages is known to lead to
reduced clearance by the immune system and, therefore, to a
potentially longer blood circulation time with a correspond-
ingly higher probability for the nanocarrier to reach its target
location in the body.45,46
In Figure 6A, the cell uptake results obtained from ﬂow
cytometry measurements after 2 and 24 h of incubation for all
liposome samples (7.5 μg mL−1) are represented. For the
formation of the protein corona, diﬀerent plasma concen-
trations (0, 5, and 100%) were chosen to detect any
concentration dependency, as observed by Monopoli et al.
for diﬀerent systems.47 Interestingly, when ﬁrst comparing the
liposome uptake behavior with and without protein corona,
there was no signiﬁcant change visible. After 2 h incubation
time, the number of positive cells was generally very low
(<10%). Liposomes functionalized with PEG chains (L-PEG)
showed an even lower cellular uptake than the other two
samples, even though their protein corona composition only
diﬀered very slightly from the unfunctionalized liposomes (L-
un). This reduced cellular uptake of L-PEG could be caused by
an inhibition of the scavenger receptor-mediated cellular
uptake. These scavenger receptors can be found on macro-
phages and were reported to recognize PEG, especially in
combination with albumin.48,49 The PEG−albumin complexes
Figure 6. (A) Inﬂuence of protein corona formation on the cellular uptake behavior of liposomes. Liposomes were either directly incubated with
RAW 264.7 cells (referred to as 0%) or preincubated with human plasma (5 or 100%) and further added to cells at a concentration of 7.5 μg mL−1.
Cellular interaction was analyzed by ﬂow cytometry after 2 and 24 h. The amount of ﬂuorescence-positive cells (%) is shown. (B) Representative
CLSM images. Liposomes were treated with 100% human plasma and incubated with RAW264.7 cells for 2 or 24 h at a concentration of 75 μg
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could potentially block the scavenger pathway and con-
sequently decrease the cellular uptake of the liposomes
employed. Additionally, small amounts of proteins released
from cells during the cell uptake experiments could also cause
this eﬀect, although no proteins were added to the culture
medium, and might then lead to the reduced uptake observed.
After 24 h, the uptake increased for all samples but most
prominently for L-hbPG. Additional cell experiments using a
higher liposome concentration (75 μg mL−1, Figure S3)
conﬁrmed the presented results (Figure 6A), and the CLSM
images veriﬁed the intracellular localization of the liposomes
(Figure 6B). As the ﬂuorescent marker used to stain the
liposomes was located in the liposome membranes, the images
indicate that the liposomes were taken up completely via the
endolysosomal pathway including their protein corona. In the
case of fusion with the cell membrane, which could also be
proposed as an interaction pathway with cells, the cell
membrane would also be stained with the liposome dye.
Because of the self-assembled and “soft” nature of liposomes, it
is not fully clear how their membrane ﬂuidity and mechanical
characteristics inﬂuence their uptake. However, as the
liposomes used in this study contained a very high Chol
content (45 mol %), their membrane supposedly was rather
stableleading to the fact that they retain their morphology
during centrifugation. In this case, their uptake mechanism
could be similar to the one of solid nanomaterials.
To sum up, hbPG did not lead to reduced cell uptake,
although the attached chains are very hydrophilic. In contrast
to the PEG functionalization with methoxy groups at the chain
termini, the hbPG chains exhibit multiple hydroxyl groups at
their ends, which in this system appear to mediate a stronger
cellular internalization into macrophages. The observed
reduction in cellular uptake for L-PEG is generally in line
with other reports for reduced unspeciﬁc uptake of PEGylated
materials but is in this case clearly not a result of the protein
corona composition. The same applies to the increase in the
cellular uptake for hbPG-functionalized liposomes, which was
also independent of the adsorbed proteins. However, it is still
possible that the diﬀerences observed in the corona of hbPG-
functionalized liposomes lead to, for example, diﬀerent
endocytosis pathways in the macrophages or variations in
other cell lines. The fact that the cellular uptake of L-hbPG
diﬀers from the one of L-PEG is interesting. Previously, a
comparable in vivo distribution of both liposomes was
observed with slightly higher amounts of hbPG liposomes in
the spleen compared to the PEGylated ones.36 As the spleen
contains over half of the monocytes in the body,50 the diﬀerent
biodistribution could be a consequence of diﬀerent macro-
phage uptake. Of course, it has to be considered that the in
vivo situation is much more complex and the interplay of
diﬀerent cell types as well as kinetic eﬀects play a role.
Generally, the cellular uptake behavior of some carrier systems
containing hbPG was already reported.51,52 However, the
results were not compared to the unfunctionalized or
PEGylated equivalents; hence, it is unclear how the introduced
hydroxyl groups aﬀected the interaction with cells. Similarly,
the eﬀect of adsorbed proteins in these studies was not
determined.
We conclude that even though protein adsorption takes
place on the liposomes, the liposomal material itself, including
surface functionalization with hydrophilic polymers, also plays
a crucial role in the biological response. This is probably a
result of the generally low amount of adsorbed proteins as
described above, so that the polymer chains used for
functionalization were still accessible. Also, the general binding
aﬃnity of adsorbed proteins might be relatively low, so that the
protein corona could be a rather dynamic structure. We explain
this low protein adsorption tendency and the associated eﬀect
of the surface functionalization with the fact that the liposomal
material underneath the polymer functionalization itself is
already very hydrophilic and similar to the composition of
cellular membranes.
As the tested liposomes showed very low protein adsorption,
and the protein corona was not the key factor for the cellular
uptake, this presents an advantage for the successful
application in patients. It was already shown that the plasma
composition is subject to individual deviations and additionally
diﬀers between healthy donors and diseased patients, leading
to a “personalized protein corona”.53−56 This means that by
reducing the overall inﬂuence of the protein corona, the
complications introduced by personalization eﬀects could also
be potentially minimized.
■ CONCLUSIONS
The investigation of the protein corona and its inﬂuence on
cellular interactions is important for the application of drug
carriers in nanomedicine, as it is commonly accepted that
adsorbed proteins are responsible for the associated biological
behavior. In this study, we investigated the protein corona of
diﬀerently functionalized liposomes (unfunctionalized, PEG,
and hbPG) and subsequently evaluated the eﬀect of
functionalization and protein adsorption on cellular uptake in
macrophages. It was found that the protein corona of all
liposome samples was surprisingly similar with small deviations
found for the hbPG-functionalized system. Additionally, the
overall adsorbed protein amount was very low compared to
other, for example, polymeric nanomaterials. Interestingly, the
macrophage uptake was then found to not primarily correlate
with the protein adsorption. More speciﬁcally, the amount of
liposomes internalized into cells remained almost unchanged
regardless of the presence or absence of a protein corona.
Instead, the diﬀerent surface functionalizations signiﬁcantly
impacted the macrophage uptake: although the internalization
of PEGylated liposomes was reduced compared to unfunction-
alized ones, hbPG functionalization resulted in the opposite
eﬀect. We tentatively attribute the minor inﬂuence of protein
corona to the fact that the hydrophilic liposomal membrane
material resulted in a generally low protein adsorption. Thus, a
signiﬁcant fraction of the attached PEG and hbPG polymer
chains was probably still accessible and, therefore, inﬂuenced
cellular interaction. In consequence, it becomes clear that the
properties of PEG and hbPG are not universally comparable
but depend on the nature of the nanocarrier they are attached
to. As such, it might be advisable to take more advantage of
hydrophilic, “body-similar” nanomaterials like liposomes for
future nanocarrier design, eventually reducing the disease-
speciﬁc protein corona eﬀects and patient variations.
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